The NEUROlogically-impaired Extubation Timing Trial

Study Purpose

This randomized controlled trial will enrol patients with acute severe brain injury who pass a spontaneous breathing trial but have decreased level of consciousness. It will directly compare

  • (1) prompt extubation vs.#46; (2) usual care, with extubation or tracheostomy timed according to physicians' discretion.
The primary outcome will be ICU free days (days spent alive and outside an ICU).

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 16 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Age > 16 years - Acute brain injury (subarachnoid hemorrhage, ischemic stroke, spontaneous intracerebral hemorrhage, seizure, traumatic brain injury, brain tumor, global cerebral anoxia/cardiac arrest, meningitis/encephalitis/cerebral abscess) that occurred within the previous 4 weeks.
  • - Receiving invasive mechanical ventilation via endotracheal tube for > 72 hours - Glasgow Coma Scale motor score 3 to 6 with improvement or no change from previous day - passed spontaneous breathing trial (SBT)

    Exclusion Criteria:

    - Previous extubation during this ICU admission - Quadriplegic - Neuromuscular disease that will result in prolong need for mechanical ventilation, including but not limited to Guillain-Barre syndrome, cervical spinal cord injury, advanced multiple sclerosis - Do-Not-Reintubate order in place - Previously randomized in this trial - Underlying pre-existing condition with expected mortality less than 6-months.
- Anticipated/scheduled for surgical procedures within 48 hours - C-spine not yet cleared for activity as tolerated (cleared for activity as tolerated while wearing hard collar is acceptable) - Currently known or suspected to have an difficult airway - Absence of an endotracheal tube cuff leak, if checked - Absence of spontaneous or induced cough - Current enrolment in an RCT that precludes NEURO-ETT co-enrollment

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT02920580
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

N/A
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Sunnybrook Health Sciences Centre
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Damon Scales, MD, PhD
Principal Investigator Affiliation Sunnybrook Health Sciences Centre
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries Canada
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Acute Brain Injury
Additional Details

Thousands of patients suffer severe brain injuries every year, from causes such as trauma, stroke, and infection. Extensive clinical research in weaning from mechanical ventilation has led to recommendations for prompt extubation following a successful trial of spontaneous breathing in general intensive care unit (ICU). However, little evidence exists to guide decisions about when to remove the breathing tube in patients with severe brain injury. It is unclear which of the following strategies would optimize important patient outcomes: prompt extubation vs.#46; waiting and extubating or performing a tracheostomy, timed according to physicians' discretion. Each strategy has associated risks: prompt extubation may lead to higher rates of extubation failure and reintubation, whereas waiting longer may expose patients to complications from prolonged mechanical ventilation and tracheostomy may lead to procedural complications (or unnecessary procedures, if prompt extubation would be successful). This trial in brain-injured patients will test which of the following will lead to better patient outcomes:

  • (1) removing the endotracheal tube promptly once a spontaneous breathing trial is passed; or (2) usual care, with the airway management strategy selected according to the preference of the treating physician.

Arms & Interventions

Arms

Active Comparator: Extubation

Extubation by removal of endotracheal tube.

Active Comparator: Usual care

The usual clinical practice is removal of the endotracheal tube (extubation), or insertion of tracheostomy, timed according to physicians' discretion

Interventions

Procedure: - Extubation

This is an extubation by removal of endotracheal tube which must be done on the day of randomization or the following day. Any decision to subsequently reintubate the patient will be left to the discretion of the clinical team. Similarly, if a tracheostomy is deemed necessary in a patient who fails the extubation attempt, this will be managed at the discretion of the treating team. If for any reason the patient is not extubated according to the randomized schedule, the reason(s) will be recorded on a protocol violation form and the site investigator will be notified. If a patient receives a tracheostomy instead of being extubated we will again record reasons for this, but the patient will be analysed in the extubation group according to the intention-to-treat principle.

Procedure: - Usual Care

Patients in this group will be treated according to usual care, which may include extubation (removal of endotracheal tube) or insertion of a tracheostomy, timed according to physicians' discretion. The inclusion of this arm will allow prompt extubation to be compared to usual practice, which often involves further observation and delayed decision-making due to clinician uncertainty about the optimal airway management strategy. Incorporation of usual care arms has been promoted as a design feature to improve the safety and interpretability of critical care clinical trials.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

University of Alberta Hospital, Edmonton, Alberta, Canada

Status

Not yet recruiting

Address

University of Alberta Hospital

Edmonton, Alberta, T6G 2B7

Site Contact

David Zygun, MD

zygun@ualberta.ca

780-492-8597

Royal Columbian Hospital, New Westminster, British Columbia, Canada

Status

Not yet recruiting

Address

Royal Columbian Hospital

New Westminster, British Columbia, V3L 3W7

Site Contact

Steven Reynolds, MD

steven.reynolds@fraserhealth.ca

4164806100

Vancouver General Hospital, Vancouver, British Columbia, Canada

Status

Not yet recruiting

Address

Vancouver General Hospital

Vancouver, British Columbia, V5Z 1M9

Site Contact

Donald Griesdale, MD

Donald.Griesdale@vch.ca

604-875-4304

Hamilton General Hospital, Hamilton, Ontario, Canada

Status

Not yet recruiting

Address

Hamilton General Hospital

Hamilton, Ontario, L8N 3Z5

Site Contact

Sunjay Sharma, MD

sharmasun@hhsc.ca

905-521-2100 #44721

Kingston General Hospital, Kingston, Ontario, Canada

Status

Not yet recruiting

Address

Kingston General Hospital

Kingston, Ontario, K7L 2V7

Site Contact

J. Gordon Boyd, MD

2jgb1@queensu.ca

613-549-6666 #6228

London Health Sciences Centre, London, Ontario, Canada

Status

Not yet recruiting

Address

London Health Sciences Centre

London, Ontario, N6A 5A5

Site Contact

Karen Bosma, MD

Karenj.Bosma@lhsc.on.ca

519-663-3531

Ottawa Hospital, Ottawa, Ontario, Canada

Status

Not yet recruiting

Address

Ottawa Hospital

Ottawa, Ontario, K1H 8L6

Site Contact

Shane English, MD

senglish@ohri.ca

613-737-8726

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Status

Recruiting

Address

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5

Site Contact

Damon Scales, MD

damon.scales@sunnybrook.ca

416-480-6100 #5291

St. Michael's Hospital, Toronto, Ontario, Canada

Status

Recruiting

Address

St. Michael's Hospital

Toronto, Ontario, M5B 1W8

Site Contact

Andrew Baker, MD

bakera@smh.ca

416-864-5559

Toronto Western Hospital, Toronto, Ontario, Canada

Status

Recruiting

Address

Toronto Western Hospital

Toronto, Ontario, M5G 2N2

Site Contact

Jeff Singh, MD

Jeff.Singh@uhn.ca

416-603-5800 #3221

Montreal, Quebec, Canada

Status

Not yet recruiting

Address

Centre hospitalier de l'Université de Montréal

Montreal, Quebec, H2X 2H8

Site Contact

Michaël Chassé, MD

michael.chasse.chum@ssss.gouv.qc.ca

514-890-8000 #30816

Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec, Canada

Status

Not yet recruiting

Address

Hôpital du Sacré-Cœur de Montréal

Montreal, Quebec, H4J 1C5

Site Contact

Emmanuel Charbonney, MD

emmanuel.charbonney@umontreal.ca

514 338 2050

L'Hôpital de l'Enfant-Jésus, Quebec City, Quebec, Canada

Status

Not yet recruiting

Address

L'Hôpital de l'Enfant-Jésus

Quebec City, Quebec, G1J 1Z4

Site Contact

Alexis Turgeon, MD

alexis.turgeon@fmed.ulaval.ca

418-649-0252 #66064

Stay Informed & Connected